Connect with us

Technology

Peerbridge Health Launches EF-ACT Pivotal Trial to Determine Ejection Fraction Severity from AI-Enabled Remote ECG Wearable

Published

on

Trial is first of its kind to measure EF severity direct-from-ECG

NEW YORK, July 24, 2024 /PRNewswire/ — Peerbridge Health today announced the beginning of enrollment for its Ejection Fraction AI-enabled Clinical Trial (EF-ACT) pivotal trial to determine Left Ventricular Ejection Fraction (LVEF) severity directly from its AI-enabled Peerbridge Cor™ remote wearable electrocardiogram (ECG) device. This will enable on-demand assessments of EF Severity on the American Society of Echocardiography scale and will be available anytime in all settings – in clinic and at home.

Ejection Fraction Severity categories help clinicians assess the severity of heart dysfunction, guiding treatment decisions and prognostic evaluations. The Ejection Fraction (EF) severity categories on the American Society of Echocardiography (ASE) scale are defined based on the percentage of blood that the left ventricle pumps out with each contraction. 

The trial, whose announcement comes following in-depth discussions with leading cardiology experts and the Food and Drug Administration, will involve approximately 1,000 patients across multiple trial centers, including Northwell Health, Hackensack Meridian Health, Mount Sinai Health System, LeBauer-Brodie Center for Cardiovascular Research at Cone Health and Orange County Heart Institute in California. This pivotal trial comes on the heels of a successful feasibility trial in 2023. 

“This is the first pivotal trial to study direct-from-ECG ejection fraction (EF) severity at this level of fidelity,” said Peerbridge Health CEO and President Chris Darland. “The findings of this trial could have a profound effect on access and affordability of cardiac care.”  

Echocardiograms are the most common measurement tool for ejection fraction, but they must be performed in a clinic or hospital setting. This can pose challenges due to delays in scheduling, limited staffing resources, lack of access, and higher costs. The Peerbridge Health platform offers a seamless remote monitoring option that is less expensive, reducing patient burden and enabling more frequent assessments. Coupled with rhythm changes, direct-from-COR EF Severity would add valuable context for clinical decision-making, enhancing intervention adjustments.

“Peerbridge’s EF technology addresses a critical gap in remote healthcare by providing a rapid, convenient, noninvasive, and cost-effective method to better understand a patient’s cardiac status,” said Nicolas Skipitaris, MD, Chairman of Cardiovascular Medicine at Northwell Health’s Westchester Hospitals. “Early and accurate remote detection of potential cardiac dysfunction allows us to intervene more quickly and more effectively, improving patient outcomes at a fraction of the cost.”

Development of the Peerbridge Health Advanced Diagnostics platform began in Spring 2023 and Ejection Fraction Severity is the first of three AI-enabled pivotal trials for Software-as-a-Medical Device (SaMD), with Heart Failure Detection and Sleep Apnea Diagnosis to follow. 

“We’re very grateful to our clinical partners and are focused on continuing to deliver innovation to care providers across the country,” Darland added.  “Our goal remains to reach the millions of aging patients who don’t have the luxury of time or money to proactively see a cardiologist to avoid a losing battle with heart disease.  The team at Peerbridge takes this responsibility seriously. I am confident that our technology will provide meaningful impact in the near- and long-term.”

About Peerbridge Health
Peerbridge Health is revolutionizing cardiac care as the first company to bring the quality and accuracy of hospital-grade cardiac diagnostics and monitoring to the home. The company’s AI-enabled device, Peerbridge Cor™, includes a three-lead, patented AECG wearable device that features a design based on the Einthoven Triangle. The Peerbridge platform leverages ECG to diagnose and monitor the most important elements of cardiac care at a lower cost than ever before. Data captured provides actionable insights that promote early invention, reduce hospital visits and saves lives. For more, go to peerbridgehealth.com or visit our LinkedIn page.

Media Contact:

Kim Mohr
Amendola Communications for Peerbridge Health
949-322-3733; kmohr@acmarketingpr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/peerbridge-health-launches-ef-act-pivotal-trial-to-determine-ejection-fraction-severity-from-ai-enabled-remote-ecg-wearable-302204799.html

SOURCE Peerbridge Health

Continue Reading

Technology

AstroRad Vest Worn by Astronauts Aboard International Space Station to Go on Display at Smithsonian National Air and Space Museum

Published

on

By

The historic exhibition follows landmark radiation protection findings from NASA’s Artemis I mission, whose AstroRad vest is separately displayed at Kennedy Space Center.

TAMPA, Fla., Oct. 30, 2026 /PRNewswire/ — StemRad, a developer of advanced radiation protection technology, shared that one of its AstroRad radiation protection vests, flown aboard the International Space Station (ISS) and worn by five space travelers, will go on display in the At Home in Space gallery at the Smithsonian’s National Air and Space Museum in Washington, D.C.

The vest was worn by four female American astronauts and an Israeli private astronaut during everyday activities aboard the ISS, including work and sleep. These in-orbit evaluations provided valuable experience with the practicality and comfort of wearable radiation protection during extended space missions.

The Smithsonian exhibition follows the recent publication of landmark scientific findings in Science Advances from NASA’s Artemis I mission. The research demonstrated AstroRad’s ability to dramatically reduce radiation exposure during potentially cancer-inducing solar radiation storms: for the August 1972 storm, which occurred between Apollo 16 and 17, a 60% reduction in dose was demonstrated (roughly 1,200 chest X-rays). This provided important evidence for protecting astronauts on future missions to the Moon and Mars.

The AstroRad vest that traveled around the Moon aboard Artemis I is separately on display at NASA’s Kennedy Space Center Visitor Complex in Florida. Together, the two exhibits trace AstroRad’s journey from operational evaluations aboard the ISS to radiation protection research beyond Earth’s magnetic field.

“Having AstroRad displayed at the Smithsonian is a tremendous honor and a proud milestone for our team,” said Dr. Oren Milstein, CEO and Co-Founder of StemRad. “Knowing that a technology we developed to help protect astronauts is now being recognized as part of the history of space exploration is incredibly rewarding. With AstroRad also on display at Kennedy Space Center following the groundbreaking Artemis I mission, we hope these exhibits will inspire future generations to tackle the challenges of human space exploration.”

“The AstroRad vest helps tell two stories in the new At Home in Space exhibit,” said Dr. Jennifer Levasseur, Museum Curator, and the lead curator for the gallery. “Importantly, the vest represents efforts to protect astronauts from the significant concern of increased radiation exposure on long duration spaceflights. It’s also an example of how technology demonstrations on the ISS will inform future human deep space exploration.” AstroRad was developed by StemRad in collaboration with Lockheed Martin to address one of the principal challenges of human space exploration: exposure to harmful ionizing radiation. The ISS operational evaluations, the Artemis I scientific results, and the Smithsonian and Kennedy Space Center exhibitions collectively highlight the growing role of wearable radiation protection in the future of human spaceflight.

About StemRad

StemRad is an American-Israeli company specializing in personal radiation protection technologies. Its solutions are designed to protect critical organs and tissues from harmful ionizing radiation while preserving mobility and operational effectiveness. StemRad develops radiation protection solutions for space exploration, emergency response, and defense applications.

Media Contact
StemRad
Tamar Cohen
+1-813-291-2303
425954@email4pr.com
www.stemrad.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/astrorad-vest-worn-by-astronauts-aboard-international-space-station-to-go-on-display-at-smithsonian-national-air-and-space-museum-302925068.html

SOURCE StemRad

Continue Reading

Technology

Three Products Featuring TCL CSOT Displays Named to TIME’s Best Inventions of 2026

Published

on

By

SHENZHEN, China, Oct. 30, 2026 /PRNewswire/ — TCL’s flagship X11L SQD-Mini LED TV, the XTEINK X4 Pro Pocket eReader and the Framework Laptop 13 Pro have been named to TIME’s Best Inventions of 2026 list. All three products feature displays supplied by TCL CSOT.

TCL X11L: Advancing Large-Screen Picture Quality

As the only Chinese TV selected in the consumer electronics category of TIME’s Best Inventions of 2026, the TCL X11L features the TCL CSOT WHVA 2.0 Ultra Panel, delivering a native contrast ratio of 7,000:1 and 100% BT.2020 color space coverage. Its display technology combines the TCL CSOT Ultra Color Filter with 20,736 Precise Dimming Zones and 10,000-nit peak HDR brightness. Powered by SQD-Mini LED technology, which delivers an industry-leading color gamut, the X11L captures subtle variations in light, further advancing large-screen picture quality.

In its Best Inventions of 2026 coverage, TIME noted that “those who manufacture TVs are constantly seeking new ways to one-up their competitors, either through unique design or unmatchable image quality.” The TCL X11L, the publication stated, “promises the latter with an LED panel that employs ‘super quantum dot’ technology, designed with the capacity to emit light at more specific nanometer wavelengths than previously available tech. The resulting image is extremely color accurate but also impressively bright.”

XTEINK X4 Pro: Bringing Reading to Your Pocket

The XTEINK X4 Pro features a 4.3-inch E Ink display that uses reflective imaging technology and emits no blue light, delivering a paper-like reading experience designed to reduce eye fatigue during extended use. Its capacitive touchscreen and adjustable warm-and-cool front lighting help provide comfortable reading conditions throughout the day and night.

TIME wrote, “While the most popular e-readers are smaller than a hardcover, many are still a bit too large for true grab-and-go convenience. XTEINK filled the gap with its X3 and X4 e-readers.” Beyond its compact size, the XTEINK X4 Pro further enhances the reading experience with an upgraded, higher-capacity battery, making pocket-sized reading convenient at any time of day or night.

Framework Laptop 13 Pro: A Repairable, Upgradeable Laptop

The Framework Laptop 13 Pro combines a modular, repairable design with a custom 13.5-inch 2.8K touchscreen supplied by TCL CSOT. The display module measures 2.0 mm thick on the device side and 2.1 mm on the PCB side, with a weight of only 180 g, supporting the laptop’s modular architecture. The updated model also features a 74 Wh battery and a haptic trackpad, while its modular design allows users to replace or upgrade components and customize their configuration, from memory and keyboard options to ports.

TIME recognized the laptop for making high-performance computing more repairable and user-customizable. The newly updated Framework Laptop 13 Pro is more “like a bicycle,” says Framework CEO Nirav Patel. “Every part is easy to replace.” With an included screwdriver and components designed for replacement and upgrades, the laptop enables users to repair and personalize their devices themselves, and help extend product lifespan. By putting repair and customization in users’ hands, the Framework Laptop 13 Pro offers a more flexible and sustainable approach to personal computing.

The inclusion of all three products in TIME’s Best Inventions of 2026 highlights not only the strength of each product, but also TCL CSOT’s end-to-end capabilities from technology R&D to industry collaboration. Looking ahead, TCL CSOT will continue to advance multiple display technology pathways and collaborate with industry partners to expand applications across diverse scenarios, bringing high-quality, slim, eye-care and environmentally friendly display solutions to more users.

SOURCE TCL CSOT

Continue Reading

Technology

Bybit Brings Its New Financial Platform Vision to Hong Kong FinTech Week 2026

Published

on

By

LISBON, Portugal, Oct. 30, 2026 /PRNewswire/ — Bybit, the New Financial Platform trusted by more than 80 million users worldwide, announced its participation in Hong Kong FinTech Week (HKFTW) 2026, Asia’s premier fintech summit bringing together global financial leaders, regulators, and innovators at the Hong Kong Convention and Exhibition Centre from November 2 to 6, 2026.

Bybit’s senior leadership will take the stage during the two-day main conference, joining more than 1,000 global speakers and 45,000 participants from over 120 economies at one of the year’s most anticipated events for changemakers in financial services and innovation.

Ben Zhou, Co-founder and CEO of Bybit, will deliver a fireside chat on the Main Stage on November 3 titled “Bridging the Divide: The Next Chapter of TradFi & Crypto Convergence.” The session will explore how AI-driven platform innovation, institutional-grade infrastructure and asset tokenization are reshaping the boundary between traditional financial markets and the digital asset ecosystem.

Sean Ballard, Head of Derivatives and Institutional Business at Bybit, will join a panel discussion titled “The Future of Trading: Next-Generation Market Infrastructure and Liquidity” alongside executives from Panthertrade, Gravity Team and BitGo on November 3. The panel will examine how AI-driven execution models, tokenized market access, and synchronized liquidity pools are converging to create more resilient, capital-efficient and accessible trading infrastructure for professional market participants.

Themed “Fintech Nexus: Bridging the World, Building the Future”, HKFTW 2026 is organized around three strategic engines: Finance+, AI+, and Go Global, reflecting the city’s role as a super-connector between capital, innovation and international markets. The event features 10 dedicated forums, including the Digital Assets and Web3 Forum and the AI in Finance Forum, with keynote speakers from leading global financial institutions and regulators.

Bybit is not licensed by the Hong Kong Securities and Futures Commission, and its services are not available to the public in Hong Kong.

About Bybit

Bybit is The New Financial Platform.

We believe every person should have access to every financial opportunity on earth. That’s why we’re building the first intelligent platform that connects anyone, anywhere to the world’s finance.

Trusted by more than 80 million users worldwide, Bybit brings together investing, trading, payments, and wealth-building in a single secure and intelligent ecosystem. Through the combination of AI-powered technology, deep global liquidity, robust security, and transparent operations, Bybit makes global finance more accessible, efficient, and empowering for everyone.

Built for everyone. Powered by intelligence. Open to the world.

Learn more at Bybit.com.
For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | YouTube

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/bybit-brings-its-new-financial-platform-vision-to-hong-kong-fintech-week-2026-302925078.html

SOURCE Bybit

Continue Reading

Trending